Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

about

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

Item

http://www.wikidata.org/entity/Q52568627

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@en

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@nl

type

Item

label

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@en

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@nl

prefLabel

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@en

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@nl

P1476

Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

@en

P2093

Chao Gao

http://www.w3.org/2001/XMLSchema#string

Cui-Ting Peng

http://www.w3.org/2001/XMLSchema#string

Juan Rong

http://www.w3.org/2001/XMLSchema#string

Kun-Lin Liu

http://www.w3.org/2001/XMLSchema#string

Lu Xiong

http://www.w3.org/2001/XMLSchema#string

Luo-Ting Yu

http://www.w3.org/2001/XMLSchema#string

Ning-Yu Wang

http://www.w3.org/2001/XMLSchema#string

Qian Lei

http://www.w3.org/2001/XMLSchema#string

Xin Tao

http://www.w3.org/2001/XMLSchema#string

Yao-Jie Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening

Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study.

Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis

P31

scholarly article

P356

10.1128/AAC.02375-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29686156

http://www.w3.org/2001/XMLSchema#string

P932

6021648

http://www.w3.org/2001/XMLSchema#string